Topics

Indivior warns of potential loss this year as star drug loses market share

10:00 EDT 2 May 2019 | Proactive Investors

Suboxone sales have come under pressure since US authorities approved the sale of two cut-price competitors in February, and Indivior expects revenue to halve this year as a result

Original Article: Indivior warns of potential loss this year as star drug loses market share

NEXT ARTICLE

More From BioPortfolio on "Indivior warns of potential loss this year as star drug loses market share"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...